| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1084033463 |
| P356 | DOI | 10.1007/S11920-017-0769-7 |
| P932 | PMC publication ID | 5518319 |
| P698 | PubMed publication ID | 28251590 |
| P50 | author | Frances R Levin | Q88142848 |
| P2093 | author name string | Sean X Luo | |
| P2860 | cites work | Toward systems neuroscience of ADHD: a meta-analysis of 55 fMRI studies | Q22241857 |
| The dopamine theory of addiction: 40 years of highs and lows | Q22251015 | ||
| Evaluating dopamine reward pathway in ADHD: clinical implications | Q22253016 | ||
| Medication for attention deficit-hyperactivity disorder and criminality | Q24619697 | ||
| Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis | Q28256352 | ||
| Effects of methylphenidate on resting-state functional connectivity of the mesocorticolimbic dopamine pathways in cocaine addiction. | Q30416778 | ||
| Childhood and persistent ADHD symptoms associated with educational failure and long-term occupational disability in adult ADHD. | Q33663243 | ||
| Evaluation of the Persistence, Remission, and Emergence of Attention-Deficit/Hyperactivity Disorder in Young Adulthood | Q33810786 | ||
| Attention-deficit/hyperactivity disorder and risk of substance use disorder: developmental considerations, potential pathways, and opportunities for research | Q33900589 | ||
| Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study | Q33957119 | ||
| Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria | Q34049049 | ||
| Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. | Q34169007 | ||
| Mediating and moderated effects of adolescent behavioral undercontrol and parenting in the prediction of drug use disorders in emerging adulthood | Q34358528 | ||
| Is Adult ADHD a Childhood-Onset Neurodevelopmental Disorder? Evidence From a Four-Decade Longitudinal Cohort Study | Q34477320 | ||
| Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial | Q34481951 | ||
| Methylphenidate normalizes fronto-striatal underactivation during interference inhibition in medication-naïve boys with attention-deficit hyperactivity disorder | Q35050238 | ||
| Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trial. | Q35151922 | ||
| Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders | Q35189691 | ||
| Acute and residual interactive effects of repeated administrations of oral methamphetamine and alcohol in humans | Q35563348 | ||
| Toward personalized smoking-cessation treatment: Using a predictive modeling approach to guide decisions regarding stimulant medication treatment of attention-deficit/hyperactivity disorder (ADHD) in smokers. | Q35588731 | ||
| Subjective effects, misuse, and adverse effects of osmotic-release methylphenidate treatment in adolescent substance abusers with attention-deficit/hyperactivity disorder | Q35625911 | ||
| Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial | Q35685121 | ||
| Predictors of treatment response in adolescents with comorbid substance use disorder and attention-deficit/hyperactivity disorder. | Q36403699 | ||
| Brain gray matter deficits at 33-year follow-up in adults with attention-deficit/hyperactivity disorder established in childhood | Q36560100 | ||
| Behavioral disinhibition and the development of early-onset addiction: common and specific influences | Q37120700 | ||
| Treating nicotine dependence by targeting attention-deficit/ hyperactivity disorder (ADHD) with OROS methylphenidate: the role of baseline ADHD severity and treatment response. | Q37625018 | ||
| Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependence. | Q38241724 | ||
| Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study | Q38415996 | ||
| Attention-Deficit/Hyperactivity Disorder Trajectories From Childhood to Young Adulthood: Evidence From a Birth Cohort Supporting a Late-Onset Syndrome | Q39756875 | ||
| ADHD Is Highly Prevalent in Patients Seeking Treatment for Cannabis Use Disorders | Q39873202 | ||
| Reward anticipation and outcomes in adult males with attention-deficit/hyperactivity disorder. | Q40155298 | ||
| Co-Occurrence of Substance-Related and Other Mental Health Disorders Among Adolescent Cannabis Users | Q40827027 | ||
| Persistence and Subtype Stability of ADHD Among Substance Use Disorder Treatment Seekers. | Q40961281 | ||
| Long-term outcomes of pharmacologically treated versus non-treated adults with ADHD and substance use disorder: a naturalistic study | Q41709856 | ||
| Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. | Q43805376 | ||
| Is Adult-Onset ADHD a Distinct Entity? | Q44130739 | ||
| Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers | Q44132704 | ||
| Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. | Q44186906 | ||
| Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies | Q44297948 | ||
| Attention deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment | Q44352666 | ||
| Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. | Q44564871 | ||
| Response to cocaine, alone and in combination with methylphenidate, in cocaine abusers with ADHD. | Q46742376 | ||
| Delay discounting in currently using and currently abstinent cocaine-dependent outpatients and non-drug-using matched controls | Q46763423 | ||
| Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement | Q46899798 | ||
| Nonmedical Use and Diversion of ADHD Stimulants Among U.S. Adults Ages 18-49: A National Internet Survey | Q48204458 | ||
| Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving | Q48421523 | ||
| Neural hyporesponsiveness and hyperresponsiveness during immediate and delayed reward processing in adult attention-deficit/hyperactivity disorder. | Q48957472 | ||
| Characteristics of adults with attention deficit hyperactivity disorder plus substance use disorder: the role of psychiatric comorbidity. | Q51925593 | ||
| [Substance use disorders and ADHD: an overview of recent Dutch research]. | Q52303542 | ||
| Attention-Deficit/Hyperactivity Disorder and Substance Use: Symptom Pattern and Drug Choice | Q58292539 | ||
| Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment | Q77462295 | ||
| Human sensitivity to reinforcement in operant choice: How much do consequences matter? | Q83436496 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 14 | |
| P577 | publication date | 2017-03-01 | |
| P1433 | published in | Current Psychiatry Reports | Q25245507 |
| P1476 | title | Towards Precision Addiction Treatment: New Findings in Co-morbid Substance Use and Attention-Deficit Hyperactivity Disorders | |
| P478 | volume | 19 |
Search more.